Reports
Sale
Global Recombinant Dna Technology Market Size, Share, Report: By Product: Medical, Non-Medical; By Component: Expression System, Cloning Vector; By Application: Food and Agriculture, Health and Disease, Environment, Others; By End Use; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape; 2024-2032
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Recombinant DNA Technology Market Analysis
8.1 Key Industry Highlights
8.2 Global Recombinant DNA Technology Historical Market (2018-2023)
8.3 Global Recombinant DNA Technology Market Forecast (2024-2032)
8.4 Global Recombinant DNA Technology Market by Product
8.4.1 Medical
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Type
8.4.1.3.1 Therapeutic Agent
8.4.1.3.1.1 Historical Trend (2018-2023)
8.4.1.3.1.2 Forecast Trend (2024-2032)
8.4.1.3.2 Human Protein
8.4.1.3.2.1 Historical Trend (2018-2023)
8.4.1.3.2.2 Forecast Trend (2024-2032)
8.4.1.3.3 Vaccine
8.4.1.3.3.1 Historical Trend (2018-2023)
8.4.1.3.3.2 Forecast Trend (2024-2032)
8.4.2 Non-Medical
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.2.3 Breakup by Type
8.4.2.3.1 Biotech Crops
8.4.2.3.1.1 Historical Trend (2018-2023)
8.4.2.3.1.2 Forecast Trend (2024-2032)
8.4.2.3.2 Speciality Chemicals
8.4.2.3.2.1 Historical Trend (2018-2023)
8.4.2.3.2.2 Forecast Trend (2024-2032)
8.4.2.3.3 Others
8.5 Global Recombinant DNA Technology Market by Component
8.5.1 Expression System
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.1.3 Breakup by Type
8.5.1.3.1 Mammalian
8.5.1.3.1.1 Historical Trend (2018-2023)
8.5.1.3.1.2 Forecast Trend (2024-2032)
8.5.1.3.2 Bacteria
8.5.1.3.2.1 Historical Trend (2018-2023)
8.5.1.3.2.2 Forecast Trend (2024-2032)
8.5.1.3.3 Yeast
8.5.1.3.3.1 Historical Trend (2018-2023)
8.5.1.3.3.2 Forecast Trend (2024-2032)
8.5.1.3.4 Baculovirus/Insect
8.5.1.3.4.1 Historical Trend (2018-2023)
8.5.1.3.4.2 Forecast Trend (2024-2032)
8.5.2 Cloning Vector
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.6 Global Recombinant DNA Technology Market by Application
8.6.1 Food and Agriculture
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Health and Disease
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.2.3 Breakup by Type
8.6.2.3.1 Human
8.6.2.3.1.1 Historical Trend (2018-2023)
8.6.2.3.1.2 Forecast Trend (2024-2032)
8.6.2.3.2 Animal
8.6.2.3.2.1 Historical Trend (2018-2023)
8.6.2.3.2.2 Forecast Trend (2024-2032)
8.6.3 Environment
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Global Recombinant DNA Technology Market by End Use
8.7.1 Biotechnology and Pharmaceutical Companies
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Academic and Government Research Institutes
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Others
8.8 Global Recombinant DNA Technology Market by Region
8.8.1 North America
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Europe
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Asia Pacific
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.8.4 Latin America
8.8.4.1 Historical Trend (2018-2023)
8.8.4.2 Forecast Trend (2024-2032)
8.8.5 Middle East and Africa
8.8.5.1 Historical Trend (2018-2023)
8.8.5.2 Forecast Trend (2024-2032)
9 North America Recombinant DNA Technology Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Recombinant DNA Technology Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Recombinant DNA Technology Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.2 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Recombinant DNA Technology Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Recombinant DNA Technology Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Sanofi
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Amgen Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Genentech Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 GenScript
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Profacgen.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Recombinant DNA Technology Market: Key Industry Highlights, 2018 and 2032
2. Global Recombinant DNA Technology Historical Market: Breakup by Product (USD Billion), 2018-2023
3. Global Recombinant DNA Technology Market Forecast: Breakup by Product (USD Billion), 2024-2032
4. Global Recombinant DNA Technology Historical Market: Breakup by Component Type (USD Billion), 2018-2023
5. Global Recombinant DNA Technology Market Forecast: Breakup by Component Type (USD Billion), 2024-2032
6. Global Recombinant DNA Technology Historical Market: Breakup by Application (USD Billion), 2018-2023
7. Global Recombinant DNA Technology Market Forecast: Breakup by Application (USD Billion), 2024-2032
8. Global Recombinant DNA Technology Historical Market: Breakup by End-Use (USD Billion), 2018-2023
9. Global Recombinant DNA Technology Market Forecast: Breakup by End-Use (USD Billion), 2024-2032
10. Global Recombinant DNA Technology Historical Market: Breakup by Region (USD Billion), 2018-2023
11. Global Recombinant DNA Technology Market Forecast: Breakup by Region (USD Billion), 2024-2032
12. North America Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
13. North America Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Europe Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Europe Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Asia Pacific Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Asia Pacific Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Latin America Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Latin America Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Middle East and Africa Recombinant DNA Technology Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Middle East and Africa Recombinant DNA Technology Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Global Recombinant DNA Technology Equipment Market Structure
Key Questions Answered in the Report
The market attained a value of nearly USD 740.66 billion in 2023.
The market is projected to grow at a CAGR of 6.8% in the forecast period of 2024-2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 1338.54 billion by 2032.
The major market drivers include rapid technological advancements and the growing research and development (R&D) programmes for the treatment of life-threatening diseases like cancer and diabetes.
The growing deployment of recombinant DNA technology in the agricultural sector, the wide availability of genetically modified foods, and the surging R&D activities related to genetically modified crops are the key trends fuelling the market demand.
The major regional markets for recombinant DNA technology are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The major products considered in the market report are medical and non-medical.
The significant components of recombinant DNA technology include expression system and cloning vector.
The various applications of recombinant DNA technology are food and agriculture, health and disease, and environment, among others.
The several end uses of recombinant DNA technology are biotechnology and pharmaceutical companies and academic and government research institutes, among others.
The major players in the recombinant DNA technology market are Sanofi, Amgen Inc., Genentech Inc., GenScript, and Profacgen, among others.
Analyst Review
The global recombinant DNA technology market attained a value of nearly USD 740.66 billion in 2023, driven by rapid technological advancements. Aided by the growing use of rDNA technology in the food and agricultural sector, the industry is further expected to grow at a CAGR of 6.8% in the forecast period 2024-2032 to reach USD 1338.54 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of product, the market is divided into medical and non-medical. Medical products are further divided into therapeutic agent, human protein, and vaccine. Non-medical products are further segmented into biotech crops, speciality chemicals, and others. Based on component type, the market is divided into expression system and cloning vector. Expression system is further divided into mammalian, bacteria, yeast, and baculovirus/insect. On the basis of application, the market is divided into food and agriculture, health and disease, environment, and others. Health and disease is further categorised into human and animal. Based on end use, the market is segmented into biotechnology and pharmaceutical companies, academic and government research institutions, and others. The major regional markets for recombinant DNA technology are North America, Latin America, the Asia Pacific, Europe and the Middle East and Africa. The key players in the above market are Sanofi, Amgen Inc., Genentech Inc., GenScript, and Profacgen , among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER